Fungal:
Candida spp.
Cryptococcus neoformans
Coccidioides immitis
Sporothrix schenckii
Viral:
Hepatitis B
Mumps
Rubella
Other viruses (rarely)
infectious arthritis is a prominent feature associated with Lyme disease. Chronic monoarticular arthritis is
frequently due to mycobacteria, Nocardia asteroides, and fungi. Some of the more frequently encountered
etiologic agents of infectious arthritis are listed in (Table 4)
These agents act to stimulate a host inflammatory response, which is initially responsible for the pathology of
the infection. Arthritis is also a symptom associated with infectious diseases caused by certain agents, such as
Neisseria meningitidis, group A streptococci (rheumatic fever), and Streptobacillus moniliformis, in which the
agent cannot be recovered from joint fluid.
Presumably, antigen-antibody complexes formed during active infection accumulate in a joint, initiating an
inflammatory response that is responsible for the ensuing damage.
Infections in prosthetic joints are usually associated with somewhat different etiologic agents than those in
natural joints. After insertion of the prosthesis, organisms that gained access during the surgical procedure
slowly multiply until they reach a critical mass and produce a host response. This may occur long after the
initial surgery; approximately half of all prosthetic joint infections occur more than 1 year after surgery. Skin
flora is the most common etiologic agent, with Staphylococcus epidermidis, other coagulase-negative
staphylococci, Corynebacterium spp., and Propionibacterium spp. as the most common. However,
189
Arranged by Sarah Mohssen
Section I– Microbiology By Nada Sajet
Staphylococcus aureus is also a major pathogen in this infectious disease. Alternatively, organisms may reach
joints during hematogenous spread from distant, infected sites.
Diagnosis of joint infections requires an aspiration of joint fluid for culture and microscopic examination.
Inoculating the fluid directly into blood culture bottles may prevent the fluid from clotting. Some of the fluid
may be Gram stained and inoculated onto blood as well as chocolate and anaerobic media. The use of AFB
(acid fast bacteria) and fungal media must also be considered.
BONE:
Bone Marrow Aspiration or Biopsy:
Diagnosis of diseases, including brucellosis, histoplasmosis, blastomycosis, tuberculosis, and leishmaniasis, can
sometimes be made by detection of the organisms in the bone marrow. Brucella spp. can be isolated on culture,
as can fungi, but parasitic agents must be visualized in smears or sections made from bone marrow material.
Many of the etiologic agents associated with disseminated infections in patients with human immunodeficiency
virus (HIV) may be visualized or isolated from the bone marrow. Some of these organisms include
cytomegalovirus, Cryptococcus neoformans, and Mycobacterium avium complex.
Bone Biopsy:
A small piece of infected bone is occasionally sent to the microbiology laboratory to identify the etiologic agent
of osteomyelitis (infection of bone). Patients develop osteomyelitis from hematogenous spread of an infectious
agent, invasion of bone tissue from an adjacent site (e.g., joint infection, dental infection), breakdown of tissue
caused by trauma or surgery, or lack of adequate circulation followed by colonization of a skin ulceration with
microorganisms. Once established, infections in bone may progress toward chronicity, particularly if blood
supply is insufficient in the affected area.
Staphylococcus aureus, seeded during bacteremia, is the most common etiologic agent of osteomyelitis among
patients of all age groups. The toxins and enzymes produced by this bacterium, as well as its ability to adhere to
smooth surfaces and produce a protective glycocalyx coating, seem to contribute to the organism’s
pathogenicity. Osteomyelitis in younger patients is often associated with a single agent. Such infections are
usually of hematogenous origin. Other organisms recovered from hematogenously acquired osteomyelitis
include Salmonella spp., Haemophilus spp., Enterobacteriaceae, Pseudomonasspp., Fusobacterium
necrophorum, and yeasts. S. aureus or P. aeruginosa is often recovered from cases in patients with drug
addictions. Parasites or viruses are rarely, if ever, etiologic agents of osteomyelitis. Bone biopsies from
infections that have spread to a bone from a contiguous source or that are associated with poor circulation,
especially in patients with diabetes, are likely to yield multiple isolates. Gram-negative bacilli are increasingly
common among hospitalized patients; a break in the skin (surgery or intravenous line) may precede
establishment of gram-negative osteomyelitis.
Breaks in skin from other causes, such as a bite wound or trauma, also may be the initial event leading to
underlying bone infection. For example, a human bite may lead to infection with Eikenella corrodens, whereas
an animal bite may result in Pasteurella multocida osteomyelitis.
Poor oral hygiene may lead to osteomyelitis of the jaw with Actinomyces spp., Capnocytophaga spp., and other
oral flora, particularly anaerobes. Pigmented Prevotella and Porphyromonas, Fusobacterium, and
Peptostreptococcus spp. are often involved. Pelvic infection in the female may result in a mixed aerobic and
190
Arranged by Sarah Mohssen
Section I– Microbiology By Nada Sajet
anaerobic osteomyelitis of the pubic bone. Patients with neuropathy (pathologic changes in the peripheral
nervous system) in the extremities, notably patients with diabetes, who may have poor circulation, may
experience an unrecognized or notable trauma.
They develop ulcers on the feet that do not heal, become infected, and may eventually progress to involve
underlying bone. These infections are usually polymicrobial, involving anaerobic and aerobic bacteria.
Prevotella or Porphyromonas, other gram-negative anaerobes, including the Bacteroides fragilis group,
Peptostreptococcus spp., Staphylococcus aureus, and group A and other streptococci are frequently
encountered.
Molecular testing, such as polymerase chain reaction, may be useful in determining the infectious organism
associated with the patient’s condition when the laboratory is unable to recover the organism by traditional
culture.
Solid tissues:
Pieces of tissue are removed from patients during surgical or needle biopsy procedures or may be collected at
autopsy. Any agent of infection may cause disease in tissue, and laboratory practices should be adequate to
recover bacteria, fungi, and viruses and detect the presence of parasites. Fastidious organisms (e.g., Brucella
spp.) and agents of chronic disease (e.g., systemic fungi and mycobacteria) may require special media and long
incubation periods for isolation. Some agents requiring special supportive or selective media are listed in Table
(5).
Table( 5 )Infectious Agents in Tissue Requiring Special Media:
Actinomyces spp.
Brucella spp.
Legionella spp.
Bartonella (Rochalimaea) henselae (cat-scratch disease bacilli)
Systemic fungi
Mycoplasma spp.
Mycobacterium spp.
Viruses
Laboratory diagnostic procedures:
Specimen collection and transport:
Requirements for the collection and transport of specimens from sterile body sites vary because of the
numerous types of specimens that can be collected and submitted to the laboratory for testing.
Fluids and Aspirates
Most specimens (pleural, peritoneal, pericardial, and synovial fluids) are collected by aspiration with a needle
and syringe. Collecting pericardial fluid is not without risk to the patient because the sample is collected from
the cavity immediately adjacent to the heart.
191
Arranged by Sarah Mohssen
Section I– Microbiology By Nada Sajet
Collection is performed by needle aspiration with electrocardiographic monitoring or as a surgical procedure.
Laboratory personnel should be alerted in advance of the procedure, ensuring that the appropriate media, tissue
culture media, and stain procedures are available immediately. Body fluids from sterile sites should be
transported to the laboratory in a sterile tube or airtight vial. From 1 to 5 mL of specimen is adequate for
isolation of most bacteria, but the larger the specimen, the better, particularly for isolation of M. tuberculosis
and fungi; at least 5 mL should be submitted for recovery of these organisms. Ten milliliters of fluid is
recommended for the diagnosis of peritonitis. Anaerobic transport vials are available from several sources.
These vials are prepared in an oxygenfree atmosphere and are sealed with a rubber septum or short stopper
through which the fluid is injected. Transportation of fluid in a syringe capped with a sterile rubber stopper is
not recommended. Most clinically significant anaerobic bacteria survive adequately in aerobic transport
containers (e.g., sterile, screw-capped tubes) for short periods if the specimen is purulent and of adequate
volume. However, collection in anaerobic transport media is recommended, and procedures vary in different
laboratories. Specimens received in anaerobic transport vials should be inoculated to routine aerobic (an
enriched broth, blood, chocolate, and sometimes MacConkey agar plates) and anaerobic media as quickly as
possible.
Specimens for recovery of fungi or mycobacteria may be transported in sterile, screw-capped tubes. At least 5
to 10 mL of fluid are required for adequate recovery of small numbers of organisms. If gonococci or chlamydia
are suspected, additional aliquots should be sent to the laboratory for smears and appropriate cultures. With
respect to pericardial, pleural, synovial, and peritoneal fluids, the inoculation of blood culture broth bottles at
the bedside or in the laboratory may be beneficial.
An additional specimen should be submitted to the laboratory for a Gram stain. The specimen in the blood
culture bottle is processed as a blood culture, facilitating the recovery of small numbers of organisms and
diluting out the effects of antibiotics. Citrate or sodium polyanetholsulfonate (SPS) may be used as an
anticoagulant.
Specimens collected by percutaneous needle aspiration (paracentesis) or at the time of surgery should be
inoculated into aerobic and anaerobic blood culture bottles immediately at the bedside. Fluid from CAPD
patients can be submitted to the laboratory in a sterile tube, urine cup, or the original bag. The bag is entered
with a sterile needle and syringe to withdraw fluid for culture. Fluid should be directly inoculated into blood
culture bottles (at least 20 mL [10 mL in each of two culture bottles]). Numerous studies indicate that in
addition to blood culture bottles, an adult Isolator tube is a sensitive and specific method for culture.
Bone:
Bone marrow is typically aspirated from the interstitium of the iliac crest. Usually, this material is not
processed for routine bacteria, because blood cultures are equally useful, and false-positive cultures for skin
bacteria (Staphylococcus epidermidis) are frequent. Some laboratories report good recovery from bone marrow
material injected into a pediatric Isolator tube (ISOLATOR 1.5 mL, Alere,
altham, MA) as a collection and transport device. The lytic agents within the Isolator tube are thought to lyse
cellular components, presumably freeing intracellular bacteria for enhanced recovery. Bone removed at surgery
or by percutaneous biopsy is sent to the laboratory in a sterile container.
192
Arranged by Sarah Mohssen
Section I– Microbiology By Nada Sajet
Tissue:
Tissue specimens are obtained following careful preparation of the skin. It is critical that biopsy specimens be
collected aseptically and submitted to the microbiology laboratory in a sterile container. A wide-mouthed,
screwcapped bottle or plastic container is recommended.
Anaerobic organisms survive within infected tissue long enough to be recovered from culture. A small amount
of sterile, nonbacteriostatic saline may be added to keep the specimen moist. Because homogenizing with a
tissue grinder can destroy some organisms by the shearing forces generated during grinding, it is often best to
use a sterile scissors and forceps to mince larger tissue specimens into small pieces suitable for culturing.
Note that Legionella spp. may be inhibited by saline; a section of lung should be submitted without saline for
Legionella isolation.
If anaerobic organisms are of concern, a small amount of tissue can be placed into a loosely capped, wide
mouthed plastic tube and sealed into an anaerobic pouch system, which also seals in moisture enough for
survival of organisms in tissue until the specimen is plated. The surgeon should take responsibility for seeing
that a second specimen is submitted to anatomic pathology for histologic studies. Formaldehyde-fixed tissue is
not useful for recovery of viable microorganisms, although some organisms can be recovered after very short
periods. Material from draining sinus tracts should include a portion of the tract’s wall obtained by deep
curettage. Tissue from infective endocarditis should contain a
portion of the valve and vegetation if the patient is undergoing valve replacement. In some instances,
contaminated material may be submitted for microbiologic examination. Specimens, such as tonsils or autopsy
tissue, may be surface cauterized with a heated spatula or blanched by immersing in boiling water for 5 to 10
seconds to reduce surface contamination.
The specimen may then be dissected with sterile instruments to permit culturing of the specimen’s center,
which will not be affected by the heating. Alternatively, larger tissues may be cut in half with sterile scissors or
a blade and the interior portion cultured for microbes.
Because surgical specimens are obtained at great risk and expense to the patient, and because supplementary
specimens cannot be obtained easily, it is important that the laboratory save a portion of the original tissue (if
enough material is available) in a small amount of sterile broth in the refrigerator and at –70° C (or, if
necessary, at –20° C) for at least 4 weeks in case additional studies are indicated. If the entire tissue must be
ground up for culture, a small amount of the suspension should be placed into a sterile tube and refrigerated.
Specimen processing, direct examination, and culture:
Fluids and Aspirates: Techniques for laboratory processing of sterile body fluids are similar except for those
previously discussed that are directly inoculated into blood culture bottles. Clear fluids may be concentrated by
centrifugation or filtration, whereas purulent material can be inoculated directly to media. Anybody fluid
received in the laboratory that is already clotted must be homogenized to release trapped bacteria and minced or
cut to release fungal cells. Either processing such specimens in a motorized tissue homogenizer or grinding
them manually in a mortar and pestle or glass tissue grinder allows better recovery of bacteria. Hand grinding is
often preferred, because motorized grinding can generate considerable heat and thereby kill microorganisms in
193
Arranged by Sarah Mohssen
Section I– Microbiology By Nada Sajet
the specimen. Grinding may lyse fungal elements; therefore, it is not recommended with specimens processed
for fungi. Small amounts of whole material from a clot should be aseptically cut with a scalpel and placed
directly onto media for isolation of fungi.
All fluids should be processed for direct microscopic examination. In general, if one organism is seen per oil
immersion field, at least 105 organisms per milliliter of specimen are present. In such cases, often only a few
organisms are present in normally sterile body fluids. Therefore, organisms must be concentrated in body
fluids. For microscopic examination, cytocentrifugation should be used to prepare Gram-stained
smears because organisms can be further concentrated up to 1000-fold. Body fluids should be concentrated by
either filtration or high-speed centrifugation. Once the sample is concentrated, the supernatant is aseptically
decanted or aspirated with a sterile pipette, leaving approximately 1 mL liquid in which to thoroughly mix the
sediment. Vigorous vortexing or drawing the sediment up and down into a pipette several times is required to
adequately suspend the sediment. This procedure should be done in a biologic safety cabinet. The suspension
is used to inoculate media. Direct potassium hydroxide (KOH) or calcofluor white preparations for fungi and
acid-fast stain for mycobacteria can also be performed.
Specimens for fungi should be examined by direct wet preparation or by preparing a separate smear for
periodic acid-Schiff (PAS) staining in addition to Gram stain. Either 10% KOH or calcofluor white is
recommended for visualization of fungal elements from a wet preparation.
In addition to hyphal forms, material from the thoracic cavity may contain spherules of Coccidioides or
budding yeast cells.
Lysis of leukocytes before concentration of CAPD effluents can significantly enhance recovery of organisms.
Filtration of CAPD fluid through a 0.45-mm pore membrane filter allows a greater volume of fluid to be
processed and usually yields better results. Because the numbers of infecting organisms may be low (fewer than
1 organism per 10 mL of fluid), a large quantity of fluid must be processed. Sediment obtained from at least 50
mL of fluid has been recommended. If the specimen is filtered, the filter should be cut aseptically into three
pieces, one of which is placed on chocolate agar for incubation in 5% carbon dioxide, one on MacConkey agar,
and the other on a blood agar plate for anaerobic incubation. If fluids have been concentrated by centrifugation,
the resulting sediment should be inoculated to an enrichment broth, blood, and chocolate agars. Because
these specimens are from normally sterile sites, selective media are inadvisable because they may inhibit the
isolation of anaerobes, mycobacteria, fungi, Chlamydia spp., and viruses should be used when such cultures are
clinically indicated.
Bone: Clotted bone marrow aspirates or biopsies must be homogenized or ground to release trapped
microorganisms. Specimens are inoculated to the same media as for other sterile body fluids. A special medium
for enhancement of growth of Brucella spp. and incubation in 10% carbon dioxide may be needed. A portion of
the specimen may be inoculated directly to fungal media. Sections are also made from biopsy material (bone)
for fixation, staining, and examination (usually by anatomic pathologists) for the presence of mycobacterial,
fungal, or parasitic agents. With respect to obtaining specimens from patients suspected of having
osteomyelitis, cultures taken from open wound sites above infected bone or material taken from a draining
sinus leading to an area of osteomyelitis may not reflect the actual etiologic agent of the underlying
194
Arranged by Sarah Mohssen
Section I– Microbiology By Nada Sajet
osteomyelitis. Cultures of samples of bone obtained during wound debridement surgery appear to be more
useful for directing antibiotic therapy for better clinical outcome.
Diagnosis of prosthetic (artificial) joint infections is often difficult. Unfortunately, there is no universally
accepted definition for the diagnosis of infection in the absence of microbiologic evidence because clinical
symptoms such as pain do not differentiate infection from mechanical joint failure. There is no standardized
approach to the laboratory diagnosis of these infections, and published data are conflicting. Further
complicating the diagnosis is that the most common bacteria causing prosthesis infections are common skin
contaminants such as coagulase-negative staphylococci. Some studies have reported that culture is relatively
insensitive, possibly because of the organisms residing in biofilms, whereas polymerase chain reaction (PCR)
assays were able to detect a majority of prosthetic joint infections. Atkins
and colleagues recommended that five or six operative bone specimens be submitted for culture and that the
cutoff for a definite diagnosis of infection be three or more of these specimens yielding the same organism.
However, a recent study using PCR and culture using multiple media types and prolonged incubation found that
appropriate culture was adequate to exclude bacterial infection in hip prostheses and PCR did not enhance
diagnostic sensitivity for infection.
Normal bone is difficult to break up; however, most infected bone is soft and necrotic. Therefore, grinding the
specimen in a mortar and pestle may break off some pieces. Small shavings from the most necrotic-looking
areas of the bone specimen may sometimes be scraped off aseptically and inoculated to media. Pieces should be
placed directly into media for recovery of fungi. Small bits of bone can be ground with sterile broth to form a
suspension for bacteriologic and mycobacterial cultures.
If anaerobes are to be recovered, all manipulations are best performed in an anaerobic chamber. If such an
environment is unavailable, microbiologists should work quickly within a biosafety cabinet to inoculate
prereduced anaerobic plates and broth with material from the bone.
Solid Tissue:Tissue should be manipulated in a laminar flow biologicsafety cabinet. Processing tissue within
an anaerobic chamber is even better. The microbiologist should cut through the infected area (which is often
discolored) with a sterile scalpel blade. Half of the specimen can be used for fungal cultures and the other half
for bacterial cultures. Both types of microbial agents should be considered in all tissue specimens. Some
samples should also be sent to surgical pathology for histologic examination.
Specimens should be cultured for viruses or acid-fast bacilli when requested. Material that is to be cultured
for parasites should be finely minced or teased before inoculation into broth. Direct examination of stained
tissue for parasites is often performed in the anatomic pathology lab. Imprint cultures of tissues may yield
bacteriologic results identical to homogenates and may help differentiate microbial infection within the tissue’s
center from surface colonization (growth only at the edge).
Additional media can be inoculated for incubation at lower temperatures, which may facilitate recovery of
certain systemic fungi and mycobacteria.
Tissue may also be inoculated to tissue culture cells for isolation of viruses. Brain, lung, spinal fluid, and blood
are generally good specimens for viral isolation. Tissue may be examined by immunofluorescence for the
presence of herpes simplex virus, varicella-zoster virus, cytomegalovirus, or rabies viral particles. Lung tissue
should be examined by direct fluorescent antibody test for Legionella spp.
195
Arranged by Sarah Mohssen
Section I– Microbiology By Nada Sajet
The tissues of all fetuses, premature infants, and babies who have died of an infectious process should be
cultured for Listeria. Specimens of the brain, spinal fluid, blood, liver, and spleen are most likely to contain the
organism.
Infections of the Lower Respiratory System:
The respiratory tract can be divided into two major areas: the upper respiratory tract consists of all structures
above the larynx, whereas the lower respiratory tract follows airflow below the larynx through the trachea to the
bronchi and bronchioles and then into the alveolar spaces where gas exchange occurs.
The respiratory and gastrointestinal tracts are the two major connections between the interior of the body and
the outside environment. The respiratory tract is the pathway through which the body acquires fresh oxygen and
removes unneeded carbon dioxide. It begins with the nasal and oral passages, which humidify inspired air, and
extends past the nasopharynx and oropharynx to the trachea and then into the lungs.
The trachea divides into bronchi, which subdivide into bronchioles, the smallest branches that terminate in the
alveoli. Some 300 million alveoli are estimated to be present in the lungs; these are the primary microscopic gas
exchange structures of the respiratory tract.
Familiarization with the anatomic structure of the thoracic cavity ensures proper specimen collection from
various sites in the lower respiratory tract for processing by the laboratory. The thoracic cavity, which contains
the heart and lungs, has three partitions separated from one another by pleura.
The lungs occupy the right and left pleural cavities, whereas the mediastinum (space between the lungs) is occupied
mainly by the esophagus, trachea, large blood vessels, and heart.
Pathogenesis of the respiratory tract:
Basic concepts
Microorganisms primarily cause disease by a limited number of pathogenic mechanisms. Because these
mechanisms relate to respiratory tract infections. Encounters between the human body and microorganisms
occur many times each day. However, establishment of infection after such contact tends to be the exception
rather than the rule.
Whether an organism is successful in establishing an infection depends not only on the organism’s ability to
cause disease (pathogenicity) but also on the human host’s ability to prevent the infection.
Host Factors The human host has several mechanisms that nonspecifically protect the respiratory tract from
infection: the nasal hairs, convoluted passages, and the mucous lining of the nasal turbinates; secretory IgA and
nonspecific antibacterial substances (lysozyme) in respiratory secretions; the cilia and mucous lining of the
trachea; and reflexes such as coughing, sneezing, and swallowing. These mechanisms prevent foreign objects or
organisms from entering the bronchi and gaining access to the
lungs, which remain sterile in the healthy host. Aspiration of minor amounts of oropharyngeal material, as
occurs often during sleep, plays an important role in the pathogenesis of many types of pneumonia. Once
particles escape the mucociliary sweeping activity and enter the alveoli, alveolar macrophages ingest them and
carry them to the lymphatics. In addition to these nonspecific host defenses, normal flora of the nasopharynx
and oropharynx help prevent colonization by pathogenic organisms of the upper respiratory tract.
196
Arranged by Sarah Mohssen
Section I– Microbiology By Nada Sajet
Normal bacterial flora prevent the colonization by pathogens by competing for the same space and nutrients as
well as production of bacteriocins and metabolic products that are toxic to invading organisms.
Some of the bacteria that can be isolated as part of the indigenous flora of healthy hosts, as well as many
species that may cause disease under certain circumstances and are often isolated from the respiratory tracts of
healthy persons, are listed in Table(1).
Under certain circumstances and for unknown reasons, these colonizing organisms can cause disease—
perhaps because of previous damage by a viral infection, loss of some host immunity, or physical damage to the
respiratory epithelium (e.g., from smoking).
Differentiation of normal flora of the respiratory tract is important for determining the importance of an
isolate in the clinical laboratory. Colonization does not always represent an infection. It is important to
differentiate colonization from infection based on the specimen source, number of organisms present, and
presence or quantity of white blood cells.
(Organisms isolated from normally sterile sites in the respiratory tract by sterile methods that avoid
contamination with normal flora should be definitively identified and reported to the clinician.)
Microorganism Factors:
Organisms possess traits or produce products that promote colonization and subsequent infection in the host.
The virulence, or disease-producing capability of an organism, depends on several factors including adherence,
production of toxins, amount of growth or proliferation, tissue damage, avoiding the host immune response, and
ability to disseminate.
( Table 1) Organisms Present in the Nasopharynx and Oropharynx of Healthy Humans:
Possible Pathogens
Acinetobacter spp.
Viridans streptococci, including Streptococcus anginosus
group
Beta-hemolytic streptococci
Streptococcus pneumoniae
Staphylococcus aureus
Neisseria meningitidis
Mycoplasma spp.
Haemophilus influenzae
Haemophilus parainfluenzae
Moraxella catarrhalis
Candida albicans
Herpes simplex virus
Enterobacteriaceae
Mycobacterium spp.
Pseudomonas spp.
Burkholderia cepacia
197
Arranged by Sarah Mohssen
Section I– Microbiology By Nada Sajet
Filamentous fungi
Klebsiella ozaenae
Eikenella corrodens
Bacteroides spp.
Peptostreptococcus spp.
Actinomyces spp.
Capnocytophaga spp.
Actinobacillus spp., A. actinomycetemcomitans
Haemophilus aphrophilus
Entamoeba gingivalis
Trichomonas tenax
Rarely Pathogens
Nonhemolytic streptococci
Staphylococci
Micrococci
Corynebacterium spp.
Coagulase-negative staphylococci
Neisseria spp., other than N. gonorrhoeae and
N. meningitidis
Lactobacillus spp.
Veillonella spp.
Spirochetes
Rothia dentocariosa
Leptotrichia buccalis
Selenomonas
Wolinella
Stomatococcus mucilaginosus
Campylobacter spp.
Adherence. For any organism to cause disease, it must first gain a foothold within the respiratory tract to grow
to sufficient numbers to produce symptoms. Therefore, most etiologic agents of respiratory tract disease must
first adhere to the mucosa of the respiratory tract. The presence of normal flora and the overall state of the host
affect the ability of microorganisms to adhere. Surviving or growing on host tissue without causing overt
harmful effects is termed colonization. Except for those microorganisms inhaled directly into the lungs, all
etiologic agents of disease must first colonize the respiratory tract before they can cause harm.
Streptococcus pyogenes possess specific adherence factors such as fimbriae comprised of molecules such as
lipoteichoic acids and M proteins. These molecules appear as a thin layer of fuzz surrounding the bacteria.
Staphylococcus aureus and certain viridans streptococci are other bacteria that posses these lipoteichoic acid
adherence complexes. Many gram-negative bacteria (which do not have lipoteichoic acids), including
198
Arranged by Sarah Mohssen
Section I– Microbiology By Nada Sajet
Enterobacteriaceae, Legionella spp., Pseudomonas spp., Bordetella pertussis, and Haemophilus spp., also
adhere by means of proteinaceous finger-like surface fimbriae. Viruses possess either a hemagglutinin
(influenza and parainfluenza viruses) or other proteins that mediate their epithelial attachment.
(Table2): Respiratory Tract Pathogens:
Definite Respiratory Tract Pathogens:
Corynebacterium diphtheriae (toxin producing)
Mycobacterium tuberculosis
Mycoplasma pneumoniae
Chlamydia trachomatis
Chlamydia pneumoniae
Bordetella pertussis
Legionella spp.
Pneumocystis jiroveci (Pneumocystis carinii)
Nocardia spp.
Histoplasma capsulatum
Coccidioides immitis
Cryptococcus neoformans (may also be recovered from patients without disease)
Blastomyces dermatitidis
Viruses (respiratory syncytial virus, human metapneumovirus,
adenoviruses, enteroviruses, hantavirus, herpes simplex
virus, influenza and parainfluenza virus, rhinoviruses,severe acute respiratory syndrome)
Rare Respiratory Tract Pathogens:
Francisella tularensis
Bacillus anthracis
Yersinia pestis
Burkholderia pseudomallei
Coxiella burnetii
Chlamydia psittaci
Brucella spp.
Salmonella spp.
Pasteurella multocida
Klebsiella rhinoscleromatis
Varicella-zoster virus (VZV)
Parasites
Toxins. Certain microorganisms are almost always considered to be etiologic agents of disease if they are
present in any numbers in the respiratory tract because they possess virulence factors that are expressed in
every host. These organisms are listed in Table 2.
199
Arranged by Sarah Mohssen
Section I– Microbiology By Nada Sajet
The production of extracellular toxin was one of the first pathogenic mechanisms discovered among bacteria.
Corynebacterium diphtheriae is a classic example of a bacterium that produces disease through the action of an
extracellular toxin.
Once the organism colonizes the upper respiratory epithelium, it produces a toxin that is disseminated
systemically, adhering preferentially to central nervous system cells and muscle cells of the heart. Systemic
disease is characterized by myocarditis, peripheral neuritis, and local disease that can lead to respiratory
distress.Growth of C. diphtheriae causes necrosis and sloughing of the epithelial mucosa, producing a
“diphtheritic (pseudo) membrane,” which may extend from the anterior nasal mucosa to the bronchi or may be
limited to any area between—most often the tonsillar and peritonsillar areas. The membrane may cause sore
throat and interfere with respiration and swallowing. Although nontoxic strains of C. diphtheriae can cause
local disease, it is much milder than disease associated with toxigenic strains.
Some strains of Pseudomonas aeruginosa produce a toxin similar to diphtheria toxin. Whether this toxin
actually contributes to the pathogenesis of respiratory tract infection with P. aeruginosa has not been
established.
Bordetella pertussis, the agent of whooping cough, also produces toxins. The role of these toxins in production
of disease is not clear. They may act to inhibit the activity of phagocytic cells or to damage cells of the
respiratory tract. Staphylococcus aureus and beta-hemolytic streptococci
produce extracellular enzymes capable of damaging host cells or tissues. Extracellular products of
staphylococci aid in the production of tissue necrosis and the destruction of phagocytic cells and contribute to
the abscess formation associated with infection caused by this organism. Although S. aureus can be recovered
from throat specimens, it has not been proved to cause pharyngitis.
Enzymes of streptococci, including hyaluronidase, allow rapid dissemination of the bacteria.
Microorganism Growth. In addition to adherence and toxin production, pathogens cause disease by merely
growing in host tissue, interfering with normal tissue function, and attracting host immune effectors, such as
neutrophils and macrophages. Once these cells begin to attack the invading pathogens and repair the damaged
host tissue, an expanding reaction ensues with more nonspecific and immunologic factors being attracted to the
area, increasing the amount of host tissue damage. Respiratory viral infections usually progress in this manner,
as do many types of pneumonias, such as those caused by Streptococcus pneumoniae, S. pyogenes,
Staphylococcus aureus, Haemophilus influenzae, Neisseria meningitidis, Moraxella catarrhalis, Mycoplasma
pneumoniae, Mycobacterium tuberculosis, and most gram-negative bacilli.
Avoiding the Host Response. Another virulence mechanism present in various respiratory tract pathogens is
the ability to evade host defense mechanisms. S. pneumoniae, N. meningitidis, H. influenzae, Klebsiella
pneumoniae, mucoid P. aeruginosa, Cryptococcus neoformans, and others possess polysaccharide capsules that
serve both to prevent engulfment by phagocytic host cells and to protect somatic antigens from being exposed
to host immunoglobulins. The capsular material is produced in such abundance by certain bacteria, such as
pneumococci, that soluble polysaccharide antigen particles can bind
host antibodies, blocking them from serving as opsonins.
Vaccine consisting of capsular antigens provides host protection to infection, indicating tha
Vaccine consisting of capsular antigens provides host protection to infection, indicating that the capsular
polysaccharide is a major virulence mechanism of H. influenzae, S. pneumoniae, and N. meningitidis.
200
Arranged by Sarah Mohssen
Section I– Microbiology By Nada Sajet
Some respiratory pathogens evade the host immune system by multiplying within host cells. Chlamydia
trachomatis, Chlamydia psittaci, Chlamydia pneumoniae, and all viruses replicate within host cells. They have
evolved methods for being taken in by the “nonprofessional” phagocytic cells of the host to where they thrive
within the intracellular environment. Once within these cells, the organism is protected from host humoral
immune factors and other phagocytic cells. This protection lasts until the host cell becomes sufficiently
damaged that the organism is then recognized as foreign by the host and is attacked. A second group of
organisms that cause respiratory tract disease comprises organisms capable of survival within phagocytic host
cells (usually macrophages).
Once inside the phagocytic cell, these respiratory tract pathogens are able to multiply. Legionella, Pneumocystis
jiroveci (Pneumocystis carinii), and Histoplasma capsulatum are some of the more common intracellular
pathogens.
Mycobacterium tuberculosis is the classic representative of an intracellular pathogen. In primary tuberculosis,
the organism is carried to an alveolus in a droplet nucleus, a tiny aerosol particle containing tubercle bacilli.
Once phagocytized by alveolar macrophages, organisms are carried to the nearest lymph node, usually in the
hilar or other mediastinal chains. In the lymph node, the organisms slowly multiply within macrophages.
Ultimately,M. tuberculosis destroys the macrophage and is subsequently taken up by other phagocytic cells.
Tubercle bacilli multiply to a critical mass within the protected environment of the macrophages, which are
prevented from accomplishing phagosome-lysosome fusion capable of destroying the bacteria. Having reached
a critical mass, the organisms spill out of the destroyed macrophages,
through the lymphatics, and into the bloodstream, producing mycobacteremia and carrying tubercle bacilli to
many parts of the body. In most cases, the host immune system reacts sufficiently at this point to kill the bacilli;
however, a small reservoir of live bacteria may be left in areas of normally high oxygen concentration, such as
the apical (top) portion of the lung. These bacilli are walled off, and years later, an insult to the host, either
immunologic or physical, may cause breakdown of the focus of latent tubercle bacilli, allowing active
multiplicationvand disease (secondary tuberculosis). In certain patients with primary immune defects, the initial
bacteremia seeds bacteria throughout a compromised host, leading to disseminated or miliary tuberculosis.
Growth of the bacteria within host macrophages and histiocytes in the lung causes an influx of more effector
cells, including lymphocytes, neutrophils, and histiocytes, eventually resulting in granuloma formation, then
tissue destruction and cavity formation. The lesion consists of a semisolid, amorphous tissue mass resembling
semisoft cheese, from which it received the name caseating
No comments:
Post a Comment
اكتب تعليق حول الموضوع